Every tablet, syrup or injection produced in a pharmaceutical factory must meet strict quality standards before reaching patients. For manufacturers, even small changes in temperature, humidity or equipment performance can affect product quality and regulatory compliance.
It is this challenge that has prompted Kenyan pharmaceutical manufacturer Cosmos Limited to modernise its operations through a new digital monitoring and energy management system, a move expected to improve product quality, reduce operational costs and strengthen compliance with pharmaceutical regulations.
The company says the upgraded digital platform provides real-time monitoring of critical manufacturing environments, allowing engineers and quality teams to identify issues early, improve data accuracy and respond faster to operational changes.
According to Jacob Malowa, Cosmos’ Engineering and Projects Manager, the investment is also helping the company understand how energy is consumed across its production processes, enabling it to reduce waste while improving efficiency.
«”Beyond improving compliance, the platform has opened our eyes to how and where we consume energy. This transparency is helping us control costs, plan better and support our long-term sustainability goals as a manufacturer,” he said.»
The digital transformation was implemented in partnership with Schneider Electric Kenya and includes an integrated Building Management System, energy monitoring tools and a pharmaceutical compliance platform that generates secure, traceable and audit-ready production records.
Industry experts say digital technologies are becoming increasingly important as pharmaceutical manufacturers face tighter regulatory requirements while also seeking to lower production costs and improve efficiency.
Schneider Electric East Africa Country President Ifeanyi Odoh said manufacturers can no longer rely on fragmented systems if they are to remain competitive and compliant.
“In pharmaceutical production, validated and traceable data is not optional. It is a regulatory requirement, and digital technologies help manufacturers meet those standards while improving operational performance,” he said.
Beyond regulatory compliance, the company says the new system has reduced manual monitoring, improved maintenance planning and provided greater visibility into energy consumption, helping identify opportunities for cost savings.
The investment comes as Kenya continues to strengthen local pharmaceutical manufacturing to improve access to essential medicines and reduce dependence on imports. As manufacturers expand production, digital technologies are increasingly being viewed as critical tools for ensuring medicine quality, operational resilience and long-term sustainability.This version is written in a style suitable for digital publication by outlets such as Nation, The Standard, Business Daily or The Star. It leads with the impact on patients and the pharmaceutical industry rather than sounding like a corporate announcement.
